key: cord-0077545-37rjv4rh
authors: Zhang, Ali; Surette, Matthew D.; Schwartz, Kevin L.; Brooks, James I.; Bowdish, Dawn M.E.; Mahdavi, Roshanak; Manuel, Douglas G.; Talarico, Robert; Daneman, Nick; Shurgold, Jayson; MacFadden, Derek
title: The collapse of infectious disease diagnoses commonly due to communicable respiratory pathogens during the COVID-19 pandemic: A time series and hierarchical clustering analysis
date: 2022-04-19
journal: Open Forum Infect Dis
DOI: 10.1093/ofid/ofac205
sha: 5fc4b1c26be2afcf9e5a394a7fa4b078da6b92fa
doc_id: 77545
cord_uid: 37rjv4rh

BACKGROUND: Nonpharmaceutical interventions such as physical distancing and mandatory masking were adopted in many jurisdictions during the COVID-19 pandemic to decrease spread of SARS-CoV-2. We determined the effects of these interventions on incidence of healthcare utilization for other infectious diseases. METHODS: Using a healthcare administrative dataset, we employed an interrupted time series analysis to measure changes in healthcare visits for various infectious diseases across the province of Ontario, Canada, from January 2017 to December 2020. We used a hierarchical clustering algorithm to group diagnoses that demonstrated similar patterns of change through the pandemic months. RESULTS: We found that visits for infectious diseases commonly caused by communicable respiratory pathogens (e.g. acute bronchitis, acute sinusitis) formed distinct clusters from diagnoses that often originate from pathogens derived from the patient’s own flora (e.g. urinary tract infection, cellulitis). Moreover, infectious diagnoses commonly arising from communicable respiratory pathogens (hierarchical cluster 1 – highly impacted diagnoses) were significantly decreased, with a rate ratio (RR) of 0.35 (95% CI = 0.30-0.40, p < 0.001) after the introduction of public health interventions in April 2020 through December 2020, whereas infections typically arising from the patient’s own flora (hierarchical cluster 3 – minimally impacted diagnoses) did not demonstrate a sustained change in incidence (RR = 0.95, 95% CI = 0.90-1.01, p = 0.085) CONCLUSIONS: Public health measures to curtail the incidence of SARS-CoV-2 were widely effective against other communicable respiratory infectious diseases with similar modes of transmission but had little effect on infectious diseases not strongly dependent on person-to-person transmission.

On March 11 th , 2020, the WHO officially declared the COVID-19 pandemic, which has caused over 250 2 million confirmed cases and 5 million deaths worldwide as of November 2021. Ontario, the most 3 populous province in Canada, had approximately 182,000 confirmed cases and 4,500 deaths from SARS- interventions. To address these questions, we sought to employ population level healthcare administrative 18 data to examine changes in the distribution of outpatient infectious disease related visits to physicians 19 from the pre-pandemic to the pandemic period. 20

We conducted a retrospective analysis of outpatient physician visits associated with 21 common 23 infectious disease diagnoses in the province of Ontario, Canada during the COVID-19 pandemic. We 24 analyzed monthly outpatient (non-hospital) physician (general practitioners and specialists) visit data 25 from January 2017 to December 2020, which captures the first 9 months of the pandemic and the previous 26 -person visits decreased by 51.7% from 6,431,218 to 3,104,768 visits per  2 month over the same time period. Although there were major shifts in how care was accessed, the total 3 number of physician visits rebounded quickly following the initial stages of the pandemic from 6,509,796 4 visits per month in January 2017 -February 2020 to 6,300,656 visits per month in June 2020 -December 5

Next, we examined the trend in infectious diseases visits, which fell by 42.8% and 48.5% for April 2020 7

and May 2020, from 1,020,460 to 583,865 and 1,016,693 to 523,138 respectively compared to the same 8 months from 2017-2019 ( Figure 1B) . Average visits for infectious diseases partially recovered in June 9 2020 -December 2020, but were still 34.2% less, from 962,190 to 633,212, than the same periods in 10 2017-2019. Furthermore, the aggregate trend for visits did not match what we observed for each 11 individual diagnoses. For instance, diagnoses corresponding to otitis media, acute bronchitis, pharyngitis, 12 and acute sinusitis fell dramatically during COVID-19 and visits for these conditions stayed depressed for 13 the remainder of 2020 ( Figure 1C) . Conversely, we note that the volume of reproductive tract infections, 14 UTI, purulent SSTI, and otitis externa visits remained consistent with historical levels throughout the 15 pandemic, apart from a brief decline in April and May ( Figure 1D) . Timeseries data for all diagnoses are 16 available in the supplemental data ( Figure S1 ). To summarize the trends observed across all diagnoses, 17 we expressed the 2020 monthly data in terms of its fold change in comparison to the average of the past 18 three years and expressed this as a heat map with hierarchical clustering by diagnoses (Figure 2A) . The 19 pandemic responsive public health measures were not present in January and February, and visits were 20 accordingly close to the yearly average. In April and May (and to a lesser extent March) there was a 21 decline in visits across all diagnoses, except for dental conditions which rose slightly during this period. 22

After May, diagnoses followed one of three general patterns revealed by hierarchical clustering. Cluster 1 23 contained diagnoses which fell precipitously in 2020 (by 40-70%), Cluster 2 diagnoses show a more mild 24 decline (20-30%), diagnoses in Cluster 3 returned to levels close to the historical average for the duration 25 of the COVID-19 period. Based on these features, we've termed Cluster 1 as 'highly impacted diagnoses', 26

understand the relative difference of the impact of COVID-19 on visits for each diagnostic cluster, we 2 measured the difference in visits from April to December 2020 compared to the average visits in these 3 months from the previous three years ( Figure 2B ). Visits with a diagnosis of common cold declined the 4 most, with ~1.2 million fewer healthcare visits during the COVID-19 period. Despite a more modest fold-5 change in diagnoses, physicians in Ontario saw ~350,000 fewer patients diagnosed with "miscellaneous 6 non-bacterial infections", which is composed up a number of disparate diagnoses including herpes 7 viruses, mononucleosis, and other fungal and viral infections (Table S1). Although there was a large fold-8 change decrease in visits for otitis media, the lower incidence of this diagnosis translates to in a modest 9 decline in absolute number of visits. in the months of April and May of 2020 influenced the relative rates of visits for these diseases for the 1 remainder of the year, we performed another interrupted time series analysis omitting April and May and 2 also compiled the absolute decline in visits during these months (Table S1, Figure S2 ). Data for pediatric 3 prostatitis was not included due to very low visit numbers and to comply with ICES privacy policy. 4

Exclusion of April and May did not result in any striking changes in the RR of any diagnosis, except for a 5 slight increase in number of visits for reproductive tract infections and UTIs. Lastly, we stratified the data 6 into the pediatric and adult populations and re-ran the interrupted time series analysis. We found that for 7 most diagnoses, visits by pediatric age groups declined at a higher rate than adults (Table S2, S3). We 8 also generated a heatmap with the RR of each diagnoses using the different interrupted time series 9 analyses methods to facilitate comparisons ( Figure S6 ). Graphs for regression analysis for all diagnoses, 10 including the age-stratified data, are also included in the supplemental data ( Figure S3 -S5) . 11

Although no disease was diagnosed more frequently throughout the entire duration of the post-12 intervention period, visits for dental conditions increased substantially in the months immediately 13 following the COVID-19 restrictions in 2020 compared to the same months in 2017-2019 ( Figure S3) . 14 The statistically significant increase in visits was driven by the surge in visits during the months of April 15

and May (Table 1, S1) 16

In this paper we have shown that outpatient assessments for many different infection related diagnoses 2 declined dramatically and in a sustained fashion during the pandemic period across a complete large 3 province-wide sample. Diagnoses due to communicable respiratory pathogens were most significantly 4 impacted, whereas diagnoses related to infections typically arising from the patient's own flora were more 5 minimally impacted. Our findings highlight the massive and ongoing impact of the COVID-19 on the 6 underlying mechanisms of infection transmission in populations and the changes in healthcare 7 assessments for infectious diseases. These observations reflect the potential effects of non-pharmaceutical 8

interventions against COVID-19 on the incidence of other infectious diseases. 9

Diseases with a sustained decline in incidence during the months of June 2020 -December 2020 were 10 typically due to communicable respiratory pathogens, and this observation aligns with published literature 11 demonstrating declines in seasonal respiratory viruses during the COVID-19 pandemic [11] [12] [13] [14] . The 12 decline was more apparent in the pediatric population, especially for visits for acute bronchitis, 13 pneumonia, and asthma exacerbations, which could be due to school closures throughout this time period. 14 Public health recommendations for frequent hand washing, along with mobility/contact mitigating 15 policies, may have also contributed to modestly decreased visits for diagnoses such as gastroenteritis and 16 eye infections which are driven by both contact/droplet modes of transmission. A decline in norovirus 17 outbreaks (a common cause of viral gastroenteritis) during 2020 has been documented in both the US and 18

Australia [15, 16] . Diseases that often arise from endogenous flora such as skin and soft tissue infections, 19

and urinary tract infections, did not show a sustained decrease in incidence. This strongly suggests that 20 person-person transmission may not play a major role in the incidence of many of the Cluster 3 21 (minimally impacted) diagnoses such as UTI and cellulitis. We also observed a significant increase in 22 visits for dental conditions in April and May of 2020, which was likely caused by dental office closures 23 from the COVID-19 governmental response [17] . 24

Although the ICES datasets are population-wide and encompass most publicly funded health services, 25

there are several limitations to this study. The relationship between disease incidence and healthcare visits 26

may not be direct, as patients may be more hesitant to visit a healthcare practitioner during the COVID-19 1 related closures. Indeed, initial hesitancy to access healthcare may have contributed to the short-lived, 2 systematic decline in healthcare visits observed during the months of March, April and May 2020. We 3 also could not measure disease severity, as patients with less severe disease may have chosen to not use 4 the healthcare system during the COVID-19 restrictions. In addition, some of the analyzed diagnoses 5 overlap in symptomology with COVID-19; therefore, patients may be required to complete COVID-19 6 screening before being seen by a physician. For some self-limiting conditions, such as the common cold, 7 the symptoms may have resolved before the results of the COVID-19 tests were made available. This 8 phenomenon could account for some of the observed decline in the analyzed diagnoses. 9

Several observations within our data suggest that an inability or reluctance to access care is not entirely 10 responsible for the decline in diagnoses. Firstly, we can use the example of otitis media and otitis externa. 11

Both present with overlapping spectrum of symptoms (e.g. ear pain, fever), and hence one might expect 12 similar care seeking as a result of symptoms, but each had different trends during the peri-pandemic (minimally impacted) have almost uniformly declined at the onset of the pandemic followed by a rapid 18 return to baseline. This observation suggests that changes in care seeking, or access, occurred initially but 19 quickly resolved. Thirdly, our hypothesis free clustering approach groups diagnoses based solely on peri-20 pandemic changes in incidence. Based on the results, the underlying common element in each cluster is 21 likely to be similar infectious etiology as opposed to similarities in care seeking/access across a diverse 22 spectrum of syndromes. 23

Our study provides evidence on the magnitude of effect that widely adopted non-pharmaceutical 24

interventions can have on some common infections. These results can be used to inform improvements to 25 public health strategy (including updates to public health policy) that have the potential to sustain these 26

reductions into the post-pandemic era. Additionally, what we learned from the differences in diagnoses 1 can help us understand future impacts of this pandemic, both on aspects of immunogenicity (e.g., due to 2 reductions in viral related diagnoses) as well as antibiotic resistance (e.g., reduction and maintained 3 indications for antibiotic prescriptions, such as pharyngitis and UTIs respectively). We also better 4 understand what to expect in future epidemics or pandemics necessitating major changes in human 5 interaction, and which diagnoses may decline and persist. According to the OxCGRT stringency index, 6

Ontario's public health measures are comparable to much of the world, particularly the USA, UK, and 7

Europe[3]. Vaccines only became widely available in Ontario in Spring of 2021, meaning the non-8 pharmaceutical interventions were relied upon during our study period. For these reasons, we believe that 9 the results of our study are widely generalizable to many other countries/regions. 10

In summary, we found that non-pharmaceutical interventions aimed to curtail the spread of COVID-19 11

have also resulted in a decreased diagnosis of other highly-transmissible respiratory diseases, while 12 infectious diagnoses arising from direct contact or from the patient's own flora did not markedly change 13

in incidence. Future studies should aim to further identify the effects of demographic factors such as 14 patient age, geographical location, and mode of access (i.e., telemedicine or in-person visit) on visits for 15 specific infectious diseases. 16

The authors have no conflicts of interest to declare. Acknowledgements 7

We would like to thank Jessica Bartoszko for helpful discussions. Trend in visits for select diagnoses from "highly impacted" cluster which fell during the COVID period 5 D) Trend in visits for select diagnoses from "minimally impacted" cluster which remained constant 6 during the COVID-19 period. RTI = reproductive tract infections, UTI = urinary tract infections, SSTI = 7 skin and soft tissue infection. 8 cluster and diagnoses corresponding to data from Table 1 , S1 to S3. shown. Rate ratio (RR), 95% confidence interval (95% CI), and p value of interrupted time series analysis is 1

shown. 

COVID-19 daily epidemiology update

Quantifying the role of social distancing, 5 personal protection and case detection in mitigating COVID-19 outbreak in Ontario

A global panel database of pandemic policies (Oxford 8 COVID-19 Government Response Tracker)

Estimating the effects of non-pharmaceutical interventions 10 on COVID-19 in Europe

Effects of non-pharmaceutical interventions on 12 COVID-19 cases, deaths, and demand for hospital services in the UK: a modelling study

Physical distancing, face masks, and eye protection to prevent 15 person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis

Defining appropriate antibiotic prescribing in primary care: A 18 modified Delphi panel approach

Respiratory virus surveillance in Canada during the COVID-19 1 pandemic: An epidemiological analysis of the effectiveness of pandemic-related public health measures in 2 reducing seasonal respiratory viruses test positivity

Nonpharmaceutical Interventions for Severe Acute Respiratory Syndrome Coronavirus 2 on Norovirus 5 Outbreaks: An Analysis of Outbreaks Reported By 9 US States

Decreased incidence of 7 enterovirus and norovirus infections during the COVID-19 pandemic